Affiliation:
1. Medical school of Nanjing University
2. The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
Abstract
Abstract
Objective: To explore the clinical characteristics and prognostic influencing factors of adult autoimmune hemolytic anemia (AIHA), improve clinicians' awareness of this disease and reduce the misdiagnosis rate.
Methods: This study was a retrospective single-center research from 2018 to 2023. Clinical data from adult AIHA were analyzed.
Results: Forty-one patients were enrolled, of whom were 10 males and 31 females, average age (54.4±15.9) years. The common clinical symptoms of AIHA were anemia (97.6%), dizziness or fatigue (92.7%), jaundice (85.4%), hepatosplenomegalgia (53.7%), soy colored urine (26.8%), melena (19.5%), fever (12.2%), abdominal pain or vomiting (4.9%). The hemolytic indexes of Lactate dehydrogenase (LDH) (95.1%), total bilirubin (TBIL) (85.4%), ferritin (free) (92.7%) and reticulocyte (Ret) (97.6%) are elevated. Nine patients were misdiagnosed, with 8 patients being misdiagnosed as gastrointestinal hemorrhage and 1 patient being misdiagnosed as acute cholecystitis. The risk factors for poor prognosis were revealed through a simple analysis of hemoglobin (HB), C-reactive protein (CRP), glutamic oxaltransaminase (AST), and secondary etiology. HB level and secondary etiology were independently identified as risk factors for poor prognosis by logistic regression analysis.
Conclusion: The incidence of adult AIHA is low, and the clinical symptoms are complex and non-specific. HB level and secondary etiology were independent risk factors for poor prognosis. Coomb,s Positive is an important diagnostic method, and Coomb,s negative cannot be ruled out. It is important to be familiar with the clinical characteristics of adult AIHA, improve the understanding of AIHA, and avoid misdiagnosis and mistreatment .
Publisher
Research Square Platform LLC
Reference27 articles.
1. Guidelines for diagnosis and treatment of autoimmune hemolytic anemia(2022)[J];National Health Commission of the People's Republic of China
2. Autoimmune hemolytic anemia: causes and consequences [J];Fattizzo B;Expert Review of Clinical Immunology,2022
3. Novel insights into the treatment of complement-mediated hemolytic anemias[J];Berentsen S;Therapeutic advances in hematology,2019
4. Justand MA,Beaubois C,et.al. Reliable assessment of the incidence of childhood autoimmune hemolytic anemia[J];Aladjidi N;Pediatr Blood Cancer
5. Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment[J];Hill QA;Blood Adv,2019